Dosage and administration
As a dietary supplement, take one softgel daily with a meal. For adults only. Consult your doctor before taking any supplement.
vitaMedMD One Rx
- Manufacturer
- vitaMedMD
- Effective date
- 2012-08-17
- Label type
- DIETARY SUPPLEMENT
- Version
- 1
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 01:45:31
Label at a glance#
ProductvitaMedMD One Rx
Active ingredientascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine mononitrate, riboflavin, niacinamide, pyridoxine hydrochloride, 5-METHYLTETRAHYDROFOLIC ACID, folic acid, cyanocobalamin, biotin, calcium pantothenate, ferrous fumarate, zinc oxide, doconexent
Label structure14 sections
Contacts and useful links#
Websitewww.therapeuticsmd.com
www.TherapeuticsMD.com
www.TherapeuticsMD.comLabel contents#
Full prescribing information#
DESCRIPTION
vitaMedMD™ One Rx is a prescription prenatal/postnatal dietary supplement containing vitamins, minerals and vegetarian DHA within a purple, opaque softgel.
Supplement Facts
Serving Size: 1 Softgel
| MULTIVITAMIN/MULTIMINERAL | Amount per softgel | % Daily Value Pregnant and Nursing Women |
|---|---|---|
| Vitamin C (as ascorbic acid) | 60 mg | 100% |
| Vitamin D3 (as cholecalciferol) | 400 IU | 100% |
| Vitamin E (as dl-alpha tocopheryl acetate) | 21 IU | 70% |
| Vitamin B1 (as thiamine mononitrate) | 1.5 mg | 88% |
| Vitamin B2 (as riboflavin) | 1.7 mg | 85% |
| Vitamin B3 (as niacinamide) | 20 mg | 100% |
| Vitamin B6 (as pyridoxine HCI) | 25 mg | 1000% |
| Folate | 1 mg | 125% |
| Quatrefolic®((6S)-5-methyltetrahydrofolic acid, glucosamine salt) 600 mcg Folic acid 400 mcg | ||
| Vitamin B12 (as cyanocobalamin) | 8 mcg | 100% |
| Biotin (as d-Biotin) | 300 mcg | 100% |
| Pantothenic Acid (as d-calcium pantothenate) | 10 mg | 100% |
| Iron (as ferrous fumerate) | 30 mg | 167% |
| Zinc (as zinc oxide) | 7.5 mg | 50% |
| DHA (docosahexaenoic acid from algal oil) | 200 mg | * |
* % Daily Value Not Established
OTHER INGREDIENTS
Gelatin capsule (gelatin, purified water, vegetable glycerin), high oleic sunflower oil, beeswax, glycerol monostearate, soybean lecithin, purified water, titanium dioxide, sunflower lecithin, rosemary extract, tocopherols and ascorbyl palmitate, D&C Red #33, FD&C Red #40, FD&C Blue #1, orange essential oil.
INDICATIONS
vitaMedMD™ One Rx is a dietary supplement with DHA indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and non-lactating mothers. vitaMedMD™ One Rx can also be beneficial in improving the nutritional status of women prior to conception.
CONTRAINDICATIONS
This product is contraindicated in patients with known hypersensitivity to any of the ingredients.
WARNINGS SECTION
| WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately. |
WARNING
Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 0.1 mg daily may obscure pernicious anemia, in that hematologic remission can occur while neurological manifestations remain progressive.
WARNING
Ingestion of more than 3 grams of omega-3 fatty acids (such as DHA) per day has been shown to have potential antithrombotic effects, including an increased bleeding time and INR. Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired predisposition to bleeding.
ADVERSE REACTIONS
Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
DOSAGE AND ADMINISTRATION
As a dietary supplement, take one softgel daily with a meal. For adults only. Consult your doctor before taking any supplement.
HOW SUPPLIED
Unit dose box of 30 softgels
Product Code 10782-101-30
SAFE HANDLING WARNING SECTION
KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN.
STATEMENT OF IDENTITY SECTION
Marketed and Distributed by: TherapeuticsMD™
951 Broken Sound Parkway NW, #320, Boca Raton, Florida 33487
800.728.0009 www.TherapeuticsMD.com
Quatrefolic® is a registered trademark of Gnosis Spa.
U.S. Patent No. 7,947,662; and other patents pending.
PRINCIPAL DISPLAY PANEL - 30 Softgel Bottle Carton
Product Code 10782-101-30
vitaMedMD™
One Rx WITH Quatrefolic®
Prenatal Multivitamin
with DHA
14 Vitamins, Minerals and
200 mg of Plant-based life'sDHA™
DOCTOR-RECOMMENDED
for women planning a pregnancy,
pregnant or nursing
TherapeuticsMD™
30 SOFTGELS
DIETARY SUPPLEMENT
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 10782-101-30 | EA - Each | 10782-101 | ba16c85a-4ee5-4d8f-8156-6930b5864ed0 | 1 | 2013-02-19 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| .alpha.-tocopherol acetate, dl- | ACTIVE INGREDIENT | WR1WPI7EW8 | 1 | |
| 5-METHYLTETRAHYDROFOLIC ACID | ACTIVE INGREDIENT | TYK22LML8F | 1 | |
| ascorbic acid | ACTIVE INGREDIENT | PQ6CK8PD0R | 1 | |
| biotin | ACTIVE INGREDIENT | 6SO6U10H04 | 1 | |
| calcium pantothenate | ACTIVE INGREDIENT | 568ET80C3D | 1 | |
| cholecalciferol | ACTIVE INGREDIENT | 1C6V77QF41 | 1 | |
| cyanocobalamin | ACTIVE INGREDIENT | P6YC3EG204 | 1 | |
| doconexent | ACTIVE INGREDIENT | ZAD9OKH9JC | 1 | |
| ferrous fumarate | ACTIVE INGREDIENT | R5L488RY0Q | 1 | |
| folic acid | ACTIVE INGREDIENT | 935E97BOY8 | 1 | |
| niacinamide | ACTIVE INGREDIENT | 25X51I8RD4 | 1 | |
| pyridoxine hydrochloride | ACTIVE INGREDIENT | 68Y4CF58BV | 1 | |
| riboflavin | ACTIVE INGREDIENT | TLM2976OFR | 1 | |
| thiamine mononitrate | ACTIVE INGREDIENT | 8K0I04919X | 1 | |
| zinc oxide | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| .alpha.-tocopherol, dl- | ACTIVE MOIETY | 7QWA1RIO01 | 1 | |
| 5-METHYLTETRAHYDROFOLIC ACID | ACTIVE MOIETY | TYK22LML8F | 1 | |
| ascorbic acid | ACTIVE MOIETY | PQ6CK8PD0R | 1 | |
| biotin | ACTIVE MOIETY | 6SO6U10H04 | 1 | |
| cholecalciferol | ACTIVE MOIETY | 1C6V77QF41 | 1 | |
| cyanocobalamin | ACTIVE MOIETY | P6YC3EG204 | 1 | |
| doconexent | ACTIVE MOIETY | ZAD9OKH9JC | 1 | |
| ferrous cation | ACTIVE MOIETY | GW89581OWR | 1 | |
| folic acid | ACTIVE MOIETY | 935E97BOY8 | 1 | |
| niacinamide | ACTIVE MOIETY | 25X51I8RD4 | 1 | |
| pantothenic acid | ACTIVE MOIETY | 19F5HK2737 | 1 | |
| pyridoxine | ACTIVE MOIETY | KV2JZ1BI6Z | 1 | |
| riboflavin | ACTIVE MOIETY | TLM2976OFR | 1 | |
| thiamine ion | ACTIVE MOIETY | 4ABT0J945J | 1 | |
| zinc oxide | ACTIVE MOIETY | SOI2LOH54Z | 1 | |
| ascorbyl palmitate | INACTIVE INGREDIENT | QN83US2B0N | 1 | |
| D&C red no. 33 | INACTIVE INGREDIENT | 9DBA0SBB0L | 1 | |
| FD&C blue no. 1 | INACTIVE INGREDIENT | H3R47K3TBD | 1 | |
| FD&C red no. 40 | INACTIVE INGREDIENT | WZB9127XOA | 1 | |
| gelatin | INACTIVE INGREDIENT | 2G86QN327L | 1 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| glyceryl monostearate | INACTIVE INGREDIENT | 230OU9XXE4 | 1 | |
| lecithin, soybean | INACTIVE INGREDIENT | 1DI56QDM62 | 1 | |
| Rosemary | INACTIVE INGREDIENT | IJ67X351P9 | 1 | |
| Sunflower Oil | INACTIVE INGREDIENT | 3W1JG795YI | 1 | |
| titanium dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| tocopherol | INACTIVE INGREDIENT | R0ZB2556P8 | 1 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| yellow wax | INACTIVE INGREDIENT | 2ZA36H0S2V | 1 |
Products#
Every source-derived product name is available through these pages.
- vitaMedMD One Rx
- ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine mononitrate, riboflavin, niacinamide, pyridoxine hydrochloride, 5-METHYLTETRAHYDROFOLIC ACID, folic acid, cyanocobalamin, biotin, calcium pantothenate, ferrous fumarate, zinc oxide, and doconexent
- ascorbic acid
- cholecalciferol
- .alpha.-tocopherol acetate, dl-
- .alpha.-tocopherol, dl-
- thiamine mononitrate
- thiamine ion
- riboflavin
- niacinamide
- pyridoxine hydrochloride
- pyridoxine
- 5-METHYLTETRAHYDROFOLIC ACID
- folic acid
- cyanocobalamin
- biotin
- calcium pantothenate
- pantothenic acid
- ferrous fumarate
- ferrous cation
- zinc oxide
- doconexent
- gelatin
- water
- yellow wax
- glyceryl monostearate
- lecithin, soybean
- titanium dioxide
- tocopherol
- ascorbyl palmitate
- D&C red no. 33
- FD&C red no. 40
- FD&C blue no. 1
- Glycerin
- Sunflower Oil
- Rosemary
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 10782-101 | 10782-101-30 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| glyceryl monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | SUSPENSION / OPHTHALMIC | 0.5 %w/v | ||
| ascorbyl palmitate | ASCORBYL PALMITATE | QN83US2B0N | CREAM / TOPICAL | 0.02 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| FD&C blue no. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | DOUCHE / VAGINAL | NA | ||
| FD&C red no. 40 | FD&C RED NO. 40 | WZB9127XOA | SPONGE / TOPICAL | NA | ||
| gelatin | GELATIN | 2G86QN327L | CAPSULE, COATED / ORAL | 288 mg | ||
| FD&C red no. 40 | FD&C RED NO. 40 | WZB9127XOA | POWDER, FOR SUSPENSION / ORAL | 3 mg | ||
| yellow wax | YELLOW WAX | 2ZA36H0S2V | TABLET, EXTENDED RELEASE / ORAL | 0.01 mg | ||
| glyceryl monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | LIQUID / TOPICAL | 1 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| gelatin | GELATIN | 2G86QN327L | SOLUTION / ORAL | 34.8 mg | ||
| D&C red no. 33 | D&C RED NO. 33 | 9DBA0SBB0L | TABLET / ORAL | 0.24 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 2.2 %w/v | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| gelatin | GELATIN | 2G86QN327L | INJECTION / SUBCUTANEOUS | 16 %w/v | ||
| FD&C blue no. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | LIQUID / TOPICAL | NA | ||
| glyceryl monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | OINTMENT / TOPICAL | 5 %w/w | ||
| FD&C blue no. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | CONCENTRATE / ORAL | NA | ||
| gelatin | GELATIN | 2G86QN327L | TABLET, COATED / ORAL | 42.12 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | SHAMPOO, SUSPENSION / TOPICAL | 3 %w/v | ||
| FD&C blue no. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | SUSPENSION / ORAL | 1 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| gelatin | GELATIN | 2G86QN327L | CAPSULE / RESPIRATORY (INHALATION) | NA | ||
| FD&C red no. 40 | FD&C RED NO. 40 | WZB9127XOA | POWDER, FOR SOLUTION / ORAL | 0.33 mg/5ml | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | POWDER / ORAL | 2 mg | ||
| gelatin | GELATIN | 2G86QN327L | SYRUP / ORAL | NA | ||
| FD&C red no. 40 | FD&C RED NO. 40 | WZB9127XOA | SHAMPOO / TOPICAL | 2 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| FD&C red no. 40 | FD&C RED NO. 40 | WZB9127XOA | SUSPENSION / ORAL | 100 mg/5ml | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | SYSTEM / TOPICAL | 420 mg | ||
| gelatin | GELATIN | 2G86QN327L | GUM, CHEWING / BUCCAL | 102 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | INSERT, EXTENDED RELEASE / OPHTHALMIC | 0.4 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| D&C red no. 33 | D&C RED NO. 33 | 9DBA0SBB0L | TABLET, COATED / ORAL | NA | ||
| FD&C blue no. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | LIQUID / ORAL | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| FD&C red no. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE, LIQUID FILLED / ORAL | 1 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, COATED / ORAL | 49 mg | ||
| FD&C red no. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| D&C red no. 33 | D&C RED NO. 33 | 9DBA0SBB0L | TABLET, FILM COATED / ORAL | NA | ||
| gelatin | GELATIN | 2G86QN327L | TABLET, FILM COATED / ORAL | 57 mg | ||
| gelatin | GELATIN | 2G86QN327L | TABLET / PERIODONTAL | 3.44 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| gelatin | GELATIN | 2G86QN327L | SOLUTION / INTRAVENOUS | 34.8 mg | ||
| FD&C red no. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET / BUCCAL | 0.01 mg | ||
| FD&C blue no. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | TABLET, DELAYED RELEASE / ORAL | 0.01 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | ||
| glyceryl monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 23 mg | ||
| lecithin, soybean | SOYBEAN LECITHIN | 1DI56QDM62 | CAPSULE / ORAL | 20 mg | ||
| glyceryl monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | LOTION / TOPICAL | 177 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| gelatin | GELATIN | 2G86QN327L | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 14 mg | ||
| FD&C red no. 40 | FD&C RED NO. 40 | WZB9127XOA | DROPS / ORAL | NA | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | GRANULE, FOR SUSPENSION / ORAL | 143 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| D&C red no. 33 | D&C RED NO. 33 | 9DBA0SBB0L | SHAMPOO / TOPICAL | NA | ||
| lecithin, soybean | SOYBEAN LECITHIN | 1DI56QDM62 | TABLET / ORAL | 8 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ascorbic Acid | ASCORBIC ACID | Renova Pharmaceuticals LLC | a6481bae-2397-44c7-a51d-4f47ad91bd2c | 2026-08-19 | Warnings, Adverse reactions | ASCORBIC ACID |
| Ascor | ASCORBIC ACID | McGuff Pharmaceuticals, Inc. | 388aad52-fc01-4784-9791-1dbc80c69306 | 2026-05-29 | Warnings, Adverse reactions | ASCORBIC ACID |
| Ascorbic Acid | ASCORBIC ACID | Fresenius Kabi USA, LLC | 1606e29f-0e80-4069-b688-daab9cbff20a | 2025-12-17 | Warnings, Adverse reactions | ASCORBIC ACID |
| Skin Renewing Serum | ASCORBIC ACID | Guangzhou Danting Bath&Body Care Industry Co. Ltd | 396c2a8d-ac95-cbef-e063-6294a90aff39 | 2025-08-23 | Warnings | ASCORBIC ACID |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.